| Three novel collagen VI chains with high homology to the α3 chain SK Gara, P Grumati, A Urciuolo, P Bonaldo, B Kobbe, M Koch, ... Journal of biological chemistry 283 (16), 10658-10670, 2008 | 208 | 2008 |
| TGF-β signaling in myeloid cells is required for tumor metastasis Y Pang, SK Gara, BR Achyut, Z Li, HH Yan, CP Day, JM Weiss, ... Cancer discovery 3 (8), 936-951, 2013 | 169 | 2013 |
| Germline HABP2 mutation causing familial nonmedullary thyroid cancer SK Gara, L Jia, MJ Merino, SK Agarwal, L Zhang, M Cam, D Patel, ... New England Journal of Medicine 373 (5), 448-455, 2015 | 145 | 2015 |
| Expression of the collagen VI α5 and α6 chains in normal human skin and in skin of patients with collagen VI-related myopathies P Sabatelli, SK Gara, P Grumati, A Urciuolo, F Gualandi, R Curci, ... Journal of Investigative Dermatology 131 (1), 99-107, 2011 | 99 | 2011 |
| Expression of collagen VI α5 and α6 chains in human muscle and in Duchenne muscular dystrophy-related muscle fibrosis P Sabatelli, F Gualandi, SK Gara, P Grumati, A Zamparelli, E Martoni, ... Matrix Biology 31 (3), 187-196, 2012 | 97 | 2012 |
| Gr‐1+ CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression Z Li, Y Pang, SK Gara, BR Achyut, C Heger, PK Goldsmith, S Lonning, ... International journal of cancer 131 (11), 2584-2595, 2012 | 81 | 2012 |
| miR30a inhibits LOX expression and anaplastic thyroid cancer progression M Boufraqech, N Nilubol, L Zhang, SK Gara, SM Sadowski, A Mehta, ... Cancer research 75 (2), 367-377, 2015 | 79 | 2015 |
| Differential and restricted expression of novel collagen VI chains in mouse SK Gara, P Grumati, S Squarzoni, P Sabatelli, A Urciuolo, P Bonaldo, ... Matrix Biology 30 (4), 248-257, 2011 | 76 | 2011 |
| Metastatic adrenocortical carcinoma displays higher mutation rate and tumor heterogeneity than primary tumors SK Gara, J Lack, L Zhang, E Harris, M Cam, E Kebebew Nature Communications 9 (1), 4172, 2018 | 66 | 2018 |
| Dual inhibition of HDAC and tyrosine kinase signaling pathways with CUDC-907 inhibits thyroid cancer growth and metastases S Kotian, L Zhang, M Boufraqech, K Gaskins, SK Gara, M Quezado, ... Clinical Cancer Research 23 (17), 5044-5054, 2017 | 62 | 2017 |
| Analysis of GTPases carrying hydrophobic amino acid substitutions in lieu of the catalytic glutamine: implications for GTP hydrolysis R Mishra, SK Gara, S Mishra, B Prakash Proteins: Structure, Function, and Bioinformatics 59 (2), 332-338, 2005 | 59 | 2005 |
| RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma Y Liu-Chittenden, M Jain, K Gaskins, S Wang, MJ Merino, S Kotian, ... Oncogene 36 (25), 3541-3552, 2017 | 54 | 2017 |
| The knee osteoarthritis susceptibility locus DVWA on chromosome 3p24. 3 is the 5′ part of the split COL6A4 gene R Wagener, SK Gara, B Kobbe, M Paulsson, F Zaucke Matrix Biology 28 (6), 307-310, 2009 | 53 | 2009 |
| Distinct genome‐wide methylation patterns in sporadic and hereditary nonfunctioning pancreatic neuroendocrine tumors A Tirosh, S Mukherjee, J Lack, SK Gara, S Wang, MM Quezado, ... Cancer 125 (8), 1247-1257, 2019 | 38 | 2019 |
| HABP2 Mutation and Nonmedullary Thyroid Cancer. SK Gara, E Kebebew The New England journal of medicine 373 (21), 2086-2087, 2015 | 37 | 2015 |
| A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16 TC Pan, RZ Zhang, M Arita, S Bogdanovich, SM Adams, SK Gara, ... Journal of Biological Chemistry 289 (15), 10293-10307, 2014 | 37 | 2014 |
| Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples SK Gara, Y Wang, D Patel, Y Liu-Chittenden, M Jain, M Boufraqech, ... Nucleic Acids Research 43 (19), 9327-9339, 2015 | 31 | 2015 |
| Phase I trial of systemic intravenous infusion of interleukin‐13‐Pseudomonas exotoxin in patients with metastatic adrenocortical carcinoma Y Liu‐Chittenden, M Jain, P Kumar, D Patel, R Aufforth, V Neychev, ... Cancer medicine 4 (7), 1060-1068, 2015 | 31 | 2015 |
| Lysyl oxidase is a key player in BRAF/MAPK pathway-driven thyroid cancer aggressiveness M Boufraqech, D Patel, N Nilubol, A Powers, T King, J Shell, J Lack, ... Thyroid 29 (1), 79-92, 2019 | 30 | 2019 |
| Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response N Nilubol, M Boufraqech, L Zhang, K Gaskins, M Shen, YQ Zhang, ... Oncotarget 9 (68), 33030, 2018 | 27 | 2018 |
